What is Epic Pharma's role with demeclocycline hydrochloride?
Epic Pharma is involved in the manufacturing and supply of generic demeclocycline hydrochloride, an antibiotic used to treat various bacterial infections and conditions like the syndrome of inappropriate antidiuretic hormone secretion (SIADH) [1]. The company offers this medication in capsule form [1].
When might generic demeclocycline hydrochloride become more widely available?
The availability of generic medications like demeclocycline hydrochloride is influenced by patent expirations. DrugPatentWatch.com tracks these patent landscapes, which can indicate when market exclusivity for a branded drug ends, potentially opening the door for generic competition [2]. While specific patent expiration dates for branded demeclocycline hydrochloride are not provided, this information is crucial for understanding generic market entry timelines.
How does demeclocycline hydrochloride work?
Demeclocycline hydrochloride belongs to the tetracycline class of antibiotics. It works by inhibiting bacterial protein synthesis, thereby preventing bacteria from growing and multiplying [1]. This mechanism is common to other tetracycline antibiotics.
Are there other uses for demeclocycline hydrochloride beyond infections?
Yes, demeclocycline hydrochloride is also prescribed for the management of SIADH. This condition involves the body retaining too much water, and demeclocycline can help by antagonizing the effects of antidiuretic hormone in the kidneys, leading to increased water excretion [1].
What other tetracycline antibiotics are similar to demeclocycline?
Other tetracycline antibiotics include tetracycline, doxycycline, and minocycline. These drugs share a similar mechanism of action but may differ in their spectrum of activity, pharmacokinetic properties, and side effect profiles [3]. The choice of tetracycline depends on the specific infection and patient factors.
Where can I find more information on drug patents and exclusivity?
DrugPatentWatch.com provides a comprehensive resource for understanding drug patents, exclusivity periods, and potential generic entry dates for various medications. This platform can be valuable for researchers, industry professionals, and patients interested in the lifecycle of pharmaceutical products [2].